These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22437319)

  • 21. Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.
    Stark M; Hayward N
    Cancer Res; 2007 Mar; 67(6):2632-42. PubMed ID: 17363583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular testing in malignant melanoma.
    Grossmann AH; Grossmann KF; Wallander ML
    Diagn Cytopathol; 2012 Jun; 40(6):503-10. PubMed ID: 22619125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional expression of human-epidermal-growth-factor receptor in a melanoma cell line.
    Diaz A; Suarez E; Blanco R; Badia T; Rivero D; Lopez-Requena A; Lopez A; Montero E
    Biotechnol Appl Biochem; 2007 Sep; 48(Pt 1):21-7. PubMed ID: 17472582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of mutant p53 in melanoma.
    Stretch JR; Gatter KC; Ralfkiaer E; Lane DP; Harris AL
    Cancer Res; 1991 Nov; 51(21):5976-9. PubMed ID: 1933861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular genes possibly involved in the transformation process of the human melanoma cell line XP44 RO (Mel).
    Lafarge-Frayssinet C; Daya-Grosjean L; Estrade S; Frezouls G; Sarasin A; Cassingena R
    Anticancer Res; 1995; 15(4):1205-13. PubMed ID: 7654000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors in malignant melanoma.
    Kashani-Sabet M; Leong SP; Sagebiel R
    Surg Oncol Clin N Am; 1997 Jul; 6(3):599-623. PubMed ID: 9210357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.
    Tembe V; Schramm SJ; Stark MS; Patrick E; Jayaswal V; Tang YH; Barbour A; Hayward NK; Thompson JF; Scolyer RA; Yang YH; Mann GJ
    Pigment Cell Melanoma Res; 2015 May; 28(3):254-66. PubMed ID: 25490969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth control by tumor suppressors in malignant melanoma.
    Coleman A; Robertson G; Lugo TG
    Receptor; 1995; 5(1):9-19. PubMed ID: 7613487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A sequential method of epidermal growth factor receptor mutation detection reduces false negatives: a new case with doublet mutations of L833V and H835L in China.
    Zhuang Y; Xu J; Ma H; Zhu W; Guo L; Kang S; Guo F
    Clin Lung Cancer; 2013 May; 14(3):295-300. PubMed ID: 23313172
    [No Abstract]   [Full Text] [Related]  

  • 30. Cutaneous melanoma susceptibility and progression genes.
    de Snoo FA; Hayward NK
    Cancer Lett; 2005 Dec; 230(2):153-86. PubMed ID: 16297704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct features of distant metastasis and lymph node stage in lung adenocarcinoma patients with epidermal growth factor receptor gene mutations.
    Enomoto Y; Takada K; Hagiwara E; Kojima E
    Respir Investig; 2013 Sep; 51(3):153-7. PubMed ID: 23978641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of a novel Chinese metastatic melanoma cell line showing the new cytogenetic and biological properties.
    Yi X; Zhu G; Li Y; Liu Y; Luan Q; Dai W; Wang L; Liao W; Gao T; Li C
    Cell Biol Int; 2015 Apr; 39(4):508-14. PubMed ID: 25639772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The status of oncogenes in malignant melanoma.
    Albino AP
    Prog Clin Biol Res; 1988; 256():361-90. PubMed ID: 3285353
    [No Abstract]   [Full Text] [Related]  

  • 34. [Absence of point mutation in the 12th codon of the c-Ha-rasl transforming genes of human breast and stomach cancer, melanoma and neuroblastoma].
    Kniazev PG; Schäfer R; Willecke K; Seĭts IF
    Dokl Akad Nauk SSSR; 1985; 282(6):1487-9. PubMed ID: 4028949
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathways to melanoma.
    Ko JM; Velez NF; Tsao H
    Semin Cutan Med Surg; 2010 Dec; 29(4):210-7. PubMed ID: 21277534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular staging of melanoma.
    Shivers S; Alsarraj M; Guiliano R; Jakub J; Pendas S; Reintgen D
    Ann Surg Oncol; 2004 Nov; 11(11):953-4. PubMed ID: 15525822
    [No Abstract]   [Full Text] [Related]  

  • 37. Regulation of human estrogen receptor gene, epidermal growth factor receptor gene, and oncogenes by estrogen and antiestrogen in MCF-7 breast cancer cells.
    Murayama Y; Kurata S; Mishim Y
    Cancer Detect Prev; 1988; 13(2):103-7. PubMed ID: 3242819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of cerbB3 in naevi and malignant melanomas.
    Korabiowska M; Mirecka J; Brinck U; Hoefer K; Marx D; Schauer A
    Anticancer Res; 1996; 16(1):471-4. PubMed ID: 8615656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
    Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
    Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.
    Topcu-Yilmaz P; Kiratli H; Saglam A; Söylemezoglu F; Hascelik G
    Melanoma Res; 2010 Apr; 20(2):126-32. PubMed ID: 20061986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.